Holen Sie sich die Stockscreener-App
0.3407
0.29%
0.0043
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.83%
2.2673
|
1.9407 | 2.2115 | 2.2872 | 1.845 |
| Operating Income/Loss |
16.83%
-2.2673
|
-1.9407 | -2.2115 | -2.2872 | -1.845 |
| Nonoperating Income/Loss |
129.60%
0.0385
|
-0.1301 | 0.0197 | -0.1711 | -4.6315 |
| Income/Loss Before Equity Method Investments |
5.29%
-2.0657
|
-1.962 | -2.1608 | -2.2358 | -6.2867 |
| Income/Loss From Equity Method Investments |
49.88%
-0.1631
|
-0.1088 | -0.031 | -0.2225 | -0.1899 |
| Income/Loss From Continuing Operations Before Tax |
7.63%
-2.2288
|
-2.0708 | -2.1918 | -2.4583 | -6.4766 |
| Income/Loss From Continuing Operations After Tax |
7.63%
-2.2288
|
-2.0708 | -2.1918 | -2.4583 | -6.4766 |
|
Net Income/Loss
|
7.63%
-2.2288
|
-2.0708 | -2.1918 | -2.4583 | -6.4766 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Diluted Average Shares |
1,154%
6.5398
|
0.5213 | 5.8357 | 4.1828 | 2.9539 |
| Basic Earnings Per Share |
126.67%
-0.34
|
-0.15 | -0.38 | -0.59 | -2.19 |
| Diluted Earnings Per Share |
126.67%
-0.34
|
-0.15 | -0.38 | -0.59 | -2.19 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.12%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):